DiscoverBiovergeSpeeding Drug Development by Unlocking the Mechanism of Action of Cancer Therapies
Speeding Drug Development by Unlocking the Mechanism of Action of Cancer Therapies

Speeding Drug Development by Unlocking the Mechanism of Action of Cancer Therapies

Update: 2023-08-15
Share

Description

David Li, Co-Founder and CEO of Meliora Therapeutics, sits down with Neil to discuss why the mechanism of action for cancer therapies in development is poorly understood, how this leads to a high and costly clinical failure rate, and how Meliora's platform technology uncovers the true mechanism of action of a drug and it enables it to identify promising drug scaffolds to accelerate the development process.
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Speeding Drug Development by Unlocking the Mechanism of Action of Cancer Therapies

Speeding Drug Development by Unlocking the Mechanism of Action of Cancer Therapies

The Bioverge Podcast